HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Peter J Goadsby Selected Research
Peter J Goadsby Research Topics
Disease
197
Migraine Disorders (Migraine)
03/2022 - 03/2002
73
Headache (Headaches)
03/2022 - 05/2002
43
Cluster Headache (Cluster Headaches)
02/2022 - 05/2002
40
Pain (Aches)
01/2022 - 01/2003
19
Epilepsy (Aura)
01/2022 - 08/2005
12
Headache Disorders (Headache Syndromes)
05/2021 - 03/2003
11
Primary Headache Disorders
01/2021 - 05/2007
11
Nausea
01/2021 - 03/2004
10
Migraine with Aura (Familial Hemiplegic Migraine)
01/2022 - 03/2002
6
Paroxysmal Hemicrania (Chronic Paroxysmal Hemicrania)
01/2021 - 03/2006
5
Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 05/2004
5
Ganglion Cysts (Ganglion)
01/2021 - 07/2016
5
Hyperacusis (Phonophobia)
01/2021 - 03/2004
5
Photophobia (Light Sensitivity)
01/2019 - 03/2004
4
visual snow syndrome
01/2022 - 06/2014
4
Hyperalgesia
01/2021 - 07/2011
4
Secondary Headache Disorders
01/2020 - 08/2006
3
Fatigue
01/2021 - 11/2014
3
Hypersensitivity (Allergy)
01/2021 - 10/2015
3
Erythema
01/2020 - 09/2014
3
Prescription Drug Overuse
01/2020 - 03/2010
3
Respiratory Tract Infections (Respiratory Tract Infection)
01/2018 - 09/2014
3
Vomiting
09/2017 - 11/2014
2
Mood Disorders (Mood Disorder)
01/2021 - 02/2012
2
Vertigo (Positional Vertigo)
01/2021 - 04/2016
2
Nasopharyngitis
01/2020 - 01/2018
2
Urinary Tract Infections (Urinary Tract Infection)
01/2019 - 11/2014
Drug/Important Bio-Agent (IBA)
53
Calcitonin Gene-Related Peptide
IBA
03/2022 - 11/2002
38
Calcitonin Gene-Related Peptide Receptor Antagonists
IBA
03/2022 - 03/2004
34
Tryptamines (Triptans)
IBA
03/2021 - 05/2002
26
Monoclonal Antibodies
IBA
01/2022 - 09/2014
17
erenumab
IBA
01/2022 - 04/2016
15
Pharmaceutical Preparations
IBA
05/2021 - 09/2004
15
Indomethacin (Indometacin)
FDA Link
Generic
05/2021 - 09/2004
15
Serotonin (5 Hydroxytryptamine)
IBA
04/2020 - 10/2004
15
Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)
IBA
11/2019 - 08/2004
14
Pain-Free
IBA
01/2021 - 01/2004
13
galcanezumab
IBA
03/2021 - 09/2014
10
5-HT1F Serotonin Receptor
IBA
02/2022 - 11/2014
10
Nitroglycerin (Dynamite)
FDA Link
Generic
01/2022 - 12/2014
10
Biological Products
IBA
01/2021 - 08/2002
8
eptinezumab
IBA
01/2022 - 11/2014
8
fremanezumab
IBA
03/2021 - 07/2016
8
rimegepant sulfate
IBA
01/2021 - 02/2014
8
salicylhydroxamic acid (SHAM)
IBA
01/2020 - 04/2010
8
Dihydroergotamine (Agit)
FDA Link
Generic
07/2017 - 10/2011
7
Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)
IBA
11/2021 - 12/2014
7
Sumatriptan (Imigran)
FDA Link
Generic
01/2020 - 10/2004
7
Oxygen (Dioxygen)
IBA
12/2012 - 10/2004
6
ubrogepant
IBA
03/2021 - 01/2019
6
Neuropeptides
IBA
01/2021 - 03/2010
6
Nitric Oxide (Nitrogen Monoxide)
FDA Link
01/2020 - 10/2002
6
Topiramate (Topamax)
FDA Link
Generic
03/2014 - 08/2005
6
Vasoconstrictor Agents
IBA
01/2014 - 10/2004
5
lasmiditan
IBA
02/2022 - 01/2019
5
Peptides (Polypeptides)
IBA
11/2021 - 12/2014
5
Biomarkers (Surrogate Marker)
IBA
01/2021 - 04/2008
5
Glutamic Acid (Glutamate)
FDA Link
01/2021 - 06/2009
4
Orexins
IBA
11/2021 - 05/2007
4
Analgesics (Analgesic Drugs)
IBA
01/2021 - 03/2003
4
Acid Sensing Ion Channels
IBA
01/2021 - 10/2012
4
atogepant
IBA
01/2021 - 11/2019
4
Neurotransmitter Agents (Neurotransmitter)
IBA
01/2021 - 01/2005
4
telcagepant
IBA
01/2020 - 02/2012
4
Adenylyl Cyclases (Adenylyl Cyclase)
IBA
01/2020 - 12/2014
4
Nitric Oxide Synthase (NO Synthase)
IBA
11/2014 - 11/2002
4
Ion Channels (Ion Channel)
IBA
05/2013 - 03/2002
4
Verapamil (Calan)
FDA Link
Generic
08/2012 - 04/2004
3
Therapeutic Uses
IBA
02/2022 - 01/2005
3
Type A Botulinum Toxins (Botox)
FDA Link
01/2022 - 12/2006
3
Antibodies
IBA
01/2021 - 09/2014
3
olcegepant
IBA
01/2020 - 02/2012
3
2- (8- (3,5- difluorophenyl)- 10- oxo- 6,9- diazaspiro(4.5)dec- 9- yl)- N- (2'- oxo- 1,1',2',3- tetrahydrospiro(indene- 2,3'- pyrrolo(2,3- b)pyridin)- 5- yl)acetamide
IBA
01/2020 - 04/2011
3
Lidocaine (Xylocaine)
FDA Link
Generic
01/2018 - 06/2007
3
Glutamate Receptors (Glutamate Receptor)
IBA
03/2015 - 06/2009
3
Q-Type Calcium Channels (Q-Type Calcium Channel)
IBA
04/2014 - 03/2002
3
Anticonvulsants (Antiepileptic Drugs)
IBA
03/2014 - 09/2005
3
TRPV1 receptor
IBA
11/2012 - 11/2007
3
Dopamine (Intropin)
FDA Link
Generic
06/2010 - 03/2007
3
zolmitriptan (Zomig)
FDA Link
10/2009 - 01/2006
3
Somatostatin (Somatotropin Release-Inhibiting Factor)
IBA
01/2008 - 04/2003
2
Illicit Drugs (Recreational Drugs)
IBA
01/2022 - 05/2014
2
Insulin (Novolin)
FDA Link
11/2021 - 05/2017
2
Leptin
IBA
11/2021 - 05/2017
2
Glucagon (Glukagon)
FDA Link
11/2021 - 05/2017
2
Neuropeptide Y
IBA
11/2021 - 01/2016
2
Somatostatin Receptors (Somatostatin Receptor)
IBA
01/2021 - 06/2005
2
Memantine (Namenda)
FDA Link
01/2021 - 01/2019
2
frovatriptan (Allegro)
FDA Link
01/2021 - 09/2017
2
Hallucinogens (Psychedelics)
IBA
11/2020 - 05/2014
2
Opioid Analgesics (Opioids)
IBA
01/2020 - 01/2018
2
Type I Pituitary Adenylate Cyclase-Activating Polypeptide Receptors
IBA
01/2020 - 10/2015
Therapy/Procedure
76
Therapeutics
02/2022 - 09/2004
12
Vagus Nerve Stimulation
01/2021 - 03/2015
10
Transcranial Magnetic Stimulation
01/2021 - 04/2010
5
Aftercare (After-Treatment)
01/2020 - 12/2009
3
Contraindications
01/2021 - 09/2010
3
Drug Therapy (Chemotherapy)
11/2019 - 06/2009
3
Injections
09/2019 - 02/2014
3
Deep Brain Stimulation
06/2012 - 02/2008